NAV | $9.43 | Daily Change | -$0.01 | -0.11% |
Market Price | $9.45 | Daily Change | $0.07 | 0.75% |
The healthcare sector is under strain due to rising demand from an aging population and workforce shortages. Technology presents a viable solution, with the size of the HealthTech market expected to exceed $1T by 2032.1
The Fund invests in companies at the intersection of healthcare and technology across four key sub-themes: healthcare analytics and software, smart medical devices, AI drug discovery, and tech-enabled consumer healthcare.
A growing range of technologies are set to advance patient care, evidenced by increased AI device approvals, lower drug development costs and optimized administrative processes that are improving clinical workflows.
1Global X ETFs Forecasts, Mar 2025
Inception Date | 07/29/20 |
Total Expense Ratio | 0.50% |
Net Assets | $34.10 million |
NAV | $9.43 |
Fact Sheet | View the document |
The Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes: AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare.
The Global X HealthTech ETF (HEAL) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index.
Ticker | HEAL |
Bloomberg Index Ticker | GXHEALUN |
CUSIP | 37954Y285 |
ISIN | US37954Y2853 |
Primary Exchange | Nasdaq |
Shares Outstanding | 3,610,000 |
Number of Holdings | 38 |
30-Day Median Bid-Ask Spread | 0.67% |
30-Day SEC Yield | 0.25% |
Distribution Frequency | Semi-Annually |
NAV | $9.43 | Daily Change | -$0.01 | -0.11% |
Market Price | $9.45 | Daily Change | $0.07 | 0.75% |
As of recent month & quarter-end (03/31/25)
As of recent month & quarter-end (03/31/25)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | -1.26% | -0.63% | -0.61% |
3 Years | -13.44% | -13.38% | -13.05% |
Since Inception | -9.74% | -9.70% | -9.29% |
1 Year | -1.26% | -0.63% | -0.61% |
3 Years | -13.44% | -13.38% | -13.05% |
Since Inception | -9.74% | -9.70% | -9.29% |
Year-to-Date | -4.65% | -3.87% | -4.54% |
1 Month | -10.79% | -9.91% | -10.75% |
3 Months | -4.65% | -3.87% | -4.54% |
Since Inception | -38.06% | -37.93% | -36.62% |
Year-to-Date | -4.65% | -3.87% | -4.54% |
1 Month | -10.79% | -9.91% | -10.75% |
3 Months | -4.65% | -3.87% | -4.54% |
Since Inception | -38.06% | -37.93% | -36.62% |
The Fund’s investment objective and investment strategies changed effective April 1, 2025. Index performance (noted as "Index" above in the chart) reflects the performance of the Solactive Telemedicine & Digital Health Index prior to April 1, 2025 and the Global X HealthTech Index thereafter.
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
5.62 | HIMS | HIMS & HERS HEALTH INC | BN46048 | 29.55 | 64,728 | 1,912,712.40 |
4.57 | MASI | MASIMO CORP | B1YWR63 | 166.60 | 9,328 | 1,554,044.80 |
4.43 | DOCS | DOXIMITY INC-CLASS A | BMD22Y4 | 58.03 | 26,009 | 1,509,302.27 |
4.39 | VEEV | VEEVA SYSTEMS INC-CLASS A | BFH3N85 | 231.63 | 6,447 | 1,493,318.61 |
4.36 | PODD | INSULET CORP | B1XGNW4 | 262.61 | 5,653 | 1,484,534.33 |
4.35 | DXCM | DEXCOM INC | B0796X4 | 68.29 | 21,655 | 1,478,819.95 |
4.19 | PHIA NA | KONINKLIJKE PHILIPS NV | 5986622 | 25.24 | 56,496 | 1,426,207.42 |
4.18 | GEHC | GE HEALTHCARE TECHNOLOGY | BL6JPG8 | 80.71 | 17,628 | 1,422,755.88 |
4.11 | ISRG | INTUITIVE SURGICAL INC | 2871301 | 495.27 | 2,824 | 1,398,642.48 |
4.10 | PME AU | PRO MEDICUS LTD | 6292782 | 124.50 | 11,217 | 1,396,506.89 |
3.95 | RMD | RESMED INC | 2732903 | 223.85 | 6,002 | 1,343,547.70 |
3.66 | 241 HK | ALIBABA HEALTH | BRXVS60 | 0.61 | 2,058,900 | 1,246,406.82 |
3.63 | OTHER PAYABLE & RECEIVABLES | 1.00 | 1,235,754 | 1,235,754.04 | ||
3.61 | INSP | INSPIRE MEDICAL | BDT5KT5 | 159.28 | 7,704 | 1,227,093.12 |
3.58 | IQV | IQVIA HOLDINGS INC | BDR73G1 | 176.30 | 6,909 | 1,218,056.70 |
3.58 | IRTC | IRHYTHM TECHNOLOGIES INC | BYT4ST5 | 104.68 | 11,636 | 1,218,056.48 |
3.50 | OSCR | OSCAR HEALTH -A | BKY83Q6 | 13.11 | 90,732 | 1,189,496.52 |
3.48 | TMDX | TRANSMEDICS GROUP INC | BK6TM04 | 67.28 | 17,616 | 1,185,204.48 |
3.18 | WAY | WAYSTAR HOLDING CORP | BSWYNW8 | 37.36 | 28,941 | 1,081,235.76 |
2.53 | PRVA | PRIVIA HEALTH GROUP INC | BMDP209 | 22.45 | 38,300 | 859,835.00 |
2.51 | PRCT | PROCEPT BIOROBOTICS CORP | BMYRFV6 | 58.26 | 14,647 | 853,334.22 |
2.48 | AGL | AGILON HEALTH INC | BLR4TK4 | 4.33 | 194,944 | 844,107.52 |
2.26 | EVH | EVOLENT HEALTH INC - A | BYLY8H1 | 9.47 | 81,268 | 769,607.96 |
1.87 | TEM | TEMPUS AI INC | BSLSJJ0 | 48.24 | 13,203 | 636,912.72 |
1.70 | ALHC | ALIGNMENT HEALTHCARE INC | BNNLSZ1 | 18.62 | 31,069 | 578,504.78 |
1.69 | TNDM | TANDEM DIABETES CARE INC | BF3W461 | 19.16 | 30,025 | 575,279.00 |
1.69 | ASTH | ASTRANA HEALTH INC | BX3SQS1 | 31.01 | 18,499 | 573,653.99 |
1.62 | TDOC | TELADOC HEALTH INC | BYQRFY1 | 7.96 | 69,343 | 551,970.28 |
1.62 | OMCL | OMNICELL INC | 2789523 | 34.96 | 15,726 | 549,780.96 |
1.53 | PHR | PHREESIA INC | BKF9DQ8 | 25.56 | 20,423 | 522,011.88 |
1.53 | SDGR | SCHRODINGER INC | BKV28S8 | 19.74 | 26,381 | 520,760.94 |
0.91 | LFST | LIFESTANCE HEALT | BN0TRB7 | 6.66 | 46,252 | 308,038.32 |
0.73 | WELL CN | WELL HEALTH TECH | BF1H8W2 | 2.88 | 86,220 | 248,011.67 |
0.73 | COP GR | COMPUGROUP MEDIC | BMY7CH1 | 24.41 | 10,115 | 246,933.84 |
0.57 | SLP | SIMULATIONS PLUS INC | 2122560 | 24.52 | 7,965 | 195,301.80 |
0.33 | HCAT | HEALTH CATALYST INC | BKLCX50 | 4.53 | 24,772 | 112,217.16 |
0.30 | ABSI | ABSCI CORP | BN94K69 | 2.51 | 40,803 | 102,415.53 |
0.24 | 6523 JP | PHC HOLDINGS CORP | BMDHDB3 | 6.83 | 11,700 | 79,882.97 |
0.17 | DH | DEFINITIVE HEALT | BMGSDK2 | 2.89 | 20,519 | 59,299.91 |
0.00 | HONG KONG DOLLAR | 0.13 | 4 | 0.51 | ||
0.00 | TAIWAN DOLLAR | 0.03 | 1 | 0.03 | ||
-0.73 | CANADIAN DOLLAR | 0.69 | -357,453 | -248,360.87 | ||
-2.71 | CASH | 1.00 | -922,929 | -922,928.94 |
Sector | Weight (%) | |
---|---|---|
Health Care | 92.4 | |
Materials | 4.1 | |
Financials | 3.2 | |
Energy | 0.3 |
Industry | Weight (%) | |
---|---|---|
Health Care Equipment & Services | 67.5 | |
Pharmaceuticals, Biotechnology & Life Sciences | 19.0 | |
Health Care Equipment & Servic | 6.0 | |
Materials | 4.1 | |
Insurance | 3.2 | |
Energy | 0.3 |
Country | Weight (%) | |
---|---|---|
United States | 79.9 | |
China | 5.3 | |
Australia | 4.9 | |
Hong Kong | 4.2 | |
Netherlands | 3.5 | |
Japan | 1.1 | |
Germany | 0.8 | |
South Korea | 0.3 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. The investable universe of companies in which HEAL may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. HEAL is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
<strong><em>Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.</em></strong>
Global X Management Company LLC serves as an advisor to Global X Funds. The Global X HealthTech Index is owned and was developed by Global X Management Company LLC for use by Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments.
Effective April 1, 2025, the Global X Telemedicine & Digital Health ETF (EDOC) was renamed to Global X HealthTech ETF (HEAL), and the benchmark index was changed from the Solactive Telemedicine & Digital Health Index to the Global X HealthTech Index.